Pancreatic Cancer Research

ResearcherYanbian UniversityNo recent work listed

Junjie Piao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0016-5000; OpenAlex author ID A5041011240. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: 1 paper

Papers 4

  1. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α. Last author DOI 10.1007/s13402-021-00652-7↗
  2. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gene.2019.02.081↗
  3. Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation. Last author DOI 10.2147/cmar.s202342↗
  4. Mortalin expression in pancreatic cancer and its clinical and prognostic significance. Co-author DOI 10.1016/j.humpath.2017.03.015↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenhua Lin · 3 shared papers, 2017–2022 · strength 0.35
  2. Xuelian Cui · 2 shared papers, 2017–2022 · strength 0.24
  3. Jie Lena Sun · 2 shared papers, 2019 · strength 0.21
  4. Chunji Quan · 1 shared paper, 2019 · strength 0.11
  5. Liyan Chen · 1 shared paper, 2019 · strength 0.11
  6. Aihua Jin · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.